Possibility of autocrine β-adrenergic signaling in C2C12 myotubes

Experimental Biology and Medicine

Volumn 230, Issue 11, 2005, Pages 845-852

  Smith, Jill L ^a   Patil, Pankaj B ^a   Minteer, Shelley D ^b   Lipsitz, Jason R ^a   Fisher, Jonathan S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Saint Louis University School of Science and Engineering   (United States)

Author keywords

DOPA; Excitatory amino acid; GLUT4; Myotubes; Tyrosine hydroxylase

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CYCLIC AMP; DOPA DECARBOXYLASE INHIBITOR; GLUCOSE; INSULIN; LEVODOPA; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; MYOTUBE; NONHUMAN;

ANIMALIA;

EID: 28944455257     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523001109     Document Type: Article

References (44)

1. Boyd AE III, Lebovitz HE, Feldman JM. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alteration by L-Dopa. J Clin Endocrinol Metab 33:829-837, 1971.
2. Hirai K, Gondo K. Über Dopa-Hyperglykämie. Biochem Z 189:92-100, 1927.
3. Sirtori CR, Bolme P, Azarnoff DL. Metabolic responses to acute and chronic L-dopa administration in patients with Parkinsonism. New Engl J Med 287:729-733, 1972.
4. Hakanson R, Lundquist I, Rerup C. On the hyperglycaemic effect of DOPA and dopamine. Eur J Pharmacol 1:114-119, 1967.
5. Smith JL, Ju JS, Saha BM, Racette BA, Fisher JS. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle. J Appl Physiol 97:2339-2346, 2004.
6. Schubert D, Tarikas H, LaCorbiere M. Neurotransmitter regulation of adenosine 3′,5′-monophosphate in clonal nerve, glia, and muscle cell lines. Science 192:471-473, 1976.
7. Misu Y, Goshima Y, Ueda H, Okamura H. Neurobiology of L-DOPAergic systems. Prog Neurobiol 49:415-454, 1996.
8. Misu Y, Yue JL, Goshima Y. L-DOPA systems for blood pressure regulation in the lower brainstem. Neurosci Res 23:147-158, 1995.
9. Goshima Y, Kubo T, Misu Y. Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices. Br J Pharmacol 89:229-234, 1986.
10. Lang CH. Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor. Am J Physiol 264:R984-R991, 1993.
11. Zierath JR, Handberg A, Tally M, Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39:306-313, 1996.
12. Hunt DG, Ding Z, Ivy JL. Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake. J Appl Physiol 92:1285-1292, 2001.
13. Jue T, Rothman DL, Shulman GI, Tavitian BA, DeFronzo RA, Shulman RG. Direct observation of glycogen synthesis in human muscle with 13C NMR. Proc Natl Acad Sci USA 86:4489-4491, 1989.
14. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990.
15. Somwar R, Kim DY, Sweeney G, Huang C, Niu W, Lador C, Ramlal T, Klip A. GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 359:639-649, 2001.
16. Smith JL, Patil PB, Fisher JS. AICAR and hyperosmotic stress increase insulin-stimulated glucose transport. J Appl Physiol 99:878-883, 2005.
17. Tortorella LL, Pilch PF. C2C12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. Am J Physiol Endocrinol Metab 283:E514-E524, 2002.
18. Winder AJ. A stopped spectrophotometric assay for the dopa oxidase activity of tyrosinase. J Biochem Biophys Methods 28:173-183, 1994.
19. Klip A, Li G, Logan WJ. Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts. Am J Physiol 247:E291-E296, 1984.
20. Sugiyama A, Wiegn P, McKnite S, Lurie KG. Enzymatic fluorometric assay for tissue cAMP. J Clin Lab Anal 8:437-442, 1994.
21. Ju JS, Smith JL, Oppelt PJ, Fisher JS. Creatine feeding increases GLUT4 expression in rat skeletal muscle. Am J Physiol Endocrinol Metab 288:E347-E352, 2005.
22. Arita DY, Di Marco GS, Schor N, Casarini DE. Purification and characterization of the active form of tyrosine hydroxylase from mesangial cells in culture. J Cell Biochem 87:58-64, 2002.
23. Di Marco GS, Naffah-Mazzacoratti Md Mda G, Vio CP, Dos Santos OF, Schor N, Casarini DE. Mesangial cells are able to produce catecholamines in vitro. J Cell Biochem 89:144-151, 2003.
24. Sakamoto K, Hirshman MF, Aschenbach WG, Goodyear LJ. Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277:11910-11917, 2002.
25. Li SW, Lin TS, Minteer S, Burke WJ. 3,4-dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis. Brain Res Mol Brain Res 93:1-7, 2001.
26. McCullough LA, Westfall TC. Neuropeptide Y inhibits depolarization- stimulated catecholamine synthesis in rat pheochromocytoma cells. Eur J Pharmacol 287:271-277, 1995.
27. Tabata I, Schluter J, Gulve EA, Holloszy JO. Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes 43:903-907, 1994.
28. Gulve EA, Cartee GD, Zierath JR, Corpus VM, Holloszy JO. Reversal of enhanced muscle glucose transport after exercise: roles of insulin and glucose. Am J Physiol 259:E685-E691, 1990.
29. Treseder SA, Rose S, Summo L, Jenner P. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat. J Neural Transm 110:229-238, 2003.
30. Hunter LW, Rorie DK, Tyce GM. Inhibition of aromatic L-amino acid decarboxylase under physiological conditions: optimization of 3-hydroxybenzylhydrazine concentration to prevent concurrent inhibition of monoamine oxidase. Biochem Pharmacol 45:1363-1366, 1993.
31. Thong FS, Derave W, Kiens B, Graham TE, Urso B, Wojtaszewski JF, Hansen BF, Richter EA. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51:583-590, 2002.
32. Goshima Y, Nakamura S, Misu Y. L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Jpn J Pharmacol 53:47-56, 1990.
33. Tedroff JM. The neuroregulatory properties of L-DOPA: a review of the evidence and potential role in the treatment of Parkinson's disease. Rev Neurosci 8:195-204, 1997.
34. Nishihama M, Miyamae T, Goshima Y, Okumura F, Misu Y. An L-dopaergic relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and its cardiovascular function in anesthetized rats. Neuroscience 92:123-135, 1999.
35. Goshima Y, Nakamura S, Misu Y. L-DOPA facilitates the release of endogenous norepinephrine and dopamine via presynaptic β1- and β2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Jpn J Pharmacol 53:47-56, 1990.
36. Goshima Y, Nakamura S, Misu Y. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther 258:466-471, 1991.
37. Slominski A, Paus R. Towards defining receptors for L-tyrosine and L-dopa. Mol Cell Endocrinol 99:C7-C11, 1994.
38. Koenig H, Goldstone A, Lu CY. Androgens regulate mitochondrial cytochrome c oxidase and lysosomal hydrolases in mouse skeletal muscle. Biochem J 192:349-353, 1980.
39. Mynatt RL, Stephens JM. Agouti regulates adipocyte transcription factors. Am J Physiol Cell Physiol 280:C954-C961, 2001.
40. Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J 8:479-488, 1994.
41. Smith SR, Gawronska-Kozak B, Janderova L, Nguyen T, Murrell A, Stephens JM, Mynatt RL. Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 52:2914-2922, 2003.
42. Yu S, Castle A, Chen M, Lee R, Takeda K, Weinstein LS. Increased insulin sensitivity in Gsα knockout mice. J Biol Chem 276:19994-19998, 2001.
43. Kim S, Jee K, Kim D, Koh H, Chung J. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem 276:12864-12870, 2003.
44. Lee AD, Hansen PA, Schluter J, Gulve EA, Gao J, Holloszy JO. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol 273:C1082-C1087, 1997.